Literature DB >> 24733237

Altered cerebellar and prefrontal cortex function in rhesus monkeys that previously self-administered cocaine.

Jessica N Porter1, Davneet Minhas, Brian J Lopresti, Julie C Price, Charles W Bradberry.   

Abstract

RATIONALE: Differences in brain function in cocaine users can occur even when frank deficits are not apparent, indicating neuroadaptive consequences of use. Using monkeys to investigate altered metabolic activity following chronic cocaine self-administration allows an assessment of altered function due to cocaine use, without confounding pre-existing differences or polysubstance use often present in clinical studies.
OBJECTIVES: To evaluate alterations in metabolic function during a working memory task in the prefrontal cortex and the cerebellum following 1 year of chronic cocaine self-administration followed by a 20 month drug-free period.
METHODS: Fluorodeoxyglucose ((18)F) PET imaging was used to evaluate changes in relative regional metabolic activity associated with a delayed match to sample working memory task. Chronic cocaine animals were compared to a control group, and region of interest analyses focused on the dorsolateral prefrontal cortex (DLPFC) and cerebellum.
RESULTS: Despite no differences in task performance, in the cocaine group, the cerebellum showed greater metabolic activity during the working memory task (relative to the control task) compared to the control group. There was also a trend toward a significant difference between the groups in DLPFC activity (p = 0.054), with the cocaine group exhibiting lower DLPFC metabolic activity during the delay task (relative to the control task) than the control group.
CONCLUSION: The results support clinical indications of increased cerebellar activity associated with chronic cocaine exposure. Consistent with evidence of functional interactions between cerebellum and prefrontal cortex, these changes may serve to compensate for potential impairments in functionality of DLPFC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24733237      PMCID: PMC4194259          DOI: 10.1007/s00213-014-3560-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  45 in total

1.  Prefrontal cortical dysfunction in abstinent cocaine abusers.

Authors:  Karen Bolla; Monique Ernst; Kent Kiehl; Maria Mouratidis; Dana Eldreth; Carlo Contoreggi; John Matochik; Varughese Kurian; Jean Cadet; Alane Kimes; Frank Funderburk; Edythe London
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2004       Impact factor: 2.198

Review 2.  Cerebellum and cerebrum in adaptive control and cognition: a review.

Authors:  E J Parkins
Journal:  Biol Cybern       Date:  1997-08       Impact factor: 2.086

3.  Non-spatial memory after selective prefrontal lesions in monkeys.

Authors:  M Mishkin; F J Manning
Journal:  Brain Res       Date:  1978-03-24       Impact factor: 3.252

4.  Cerebellar transcranial magnetic stimulation impairs verbal working memory.

Authors:  John E Desmond; S H Annabel Chen; Perry B Shieh
Journal:  Ann Neurol       Date:  2005-10       Impact factor: 10.422

5.  Cognitive deficits predict low treatment retention in cocaine dependent patients.

Authors:  Efrat Aharonovich; Deborah S Hasin; Adam C Brooks; Xinhua Liu; Adam Bisaga; Edward V Nunes
Journal:  Drug Alcohol Depend       Date:  2005-09-19       Impact factor: 4.492

6.  Changes in brain glucose metabolism in cocaine dependence and withdrawal.

Authors:  N D Volkow; J S Fowler; A P Wolf; R Hitzemann; S Dewey; B Bendriem; R Alpert; A Hoff
Journal:  Am J Psychiatry       Date:  1991-05       Impact factor: 18.112

7.  Cognitive impairment in acute cocaine withdrawal.

Authors:  Brendan J Kelley; Kenneth R Yeager; Tom H Pepper; David Q Beversdorf
Journal:  Cogn Behav Neurol       Date:  2005-06       Impact factor: 1.600

8.  Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates.

Authors:  Sam A Deadwyler; Linda Porrino; Jerome M Siegel; Robert E Hampson
Journal:  J Neurosci       Date:  2007-12-26       Impact factor: 6.167

9.  Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task.

Authors:  K I Bolla; D A Eldreth; E D London; K A Kiehl; M Mouratidis; C Contoreggi; J A Matochik; V Kurian; J L Cadet; A S Kimes; F R Funderburk; M Ernst
Journal:  Neuroimage       Date:  2003-07       Impact factor: 6.556

Review 10.  Localization of cognitive operations in the human brain.

Authors:  M I Posner; S E Petersen; P T Fox; M E Raichle
Journal:  Science       Date:  1988-06-17       Impact factor: 47.728

View more
  5 in total

1.  Effects of prior cocaine self-administration on cognitive performance in female cynomolgus monkeys.

Authors:  Sarah A Kromrey; Robert W Gould; Michael A Nader; Paul W Czoty
Journal:  Psychopharmacology (Berl)       Date:  2015-01-31       Impact factor: 4.530

Review 2.  Utility of Nonhuman Primates in Substance Use Disorders Research.

Authors:  Matthew L Banks; Paul W Czoty; Sidney S Negus
Journal:  ILAR J       Date:  2017-12-01

3.  Altered activity-based sleep measures in rhesus monkeys following cocaine self-administration and abstinence.

Authors:  Jennifer A Cortes; Gustavo Gomez; Carol Ehnerd; Kate Gurnsey; Jessica Nicolazzo; Charles W Bradberry; Hank P Jedema
Journal:  Drug Alcohol Depend       Date:  2016-04-18       Impact factor: 4.492

4.  Gene Network Dysregulation in Dorsolateral Prefrontal Cortex Neurons of Humans with Cocaine Use Disorder.

Authors:  Efrain A Ribeiro; Joseph R Scarpa; Susanna P Garamszegi; Andrew Kasarskis; Deborah C Mash; Eric J Nestler
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

5.  Long-Term Cocaine Self-administration Produces Structural Brain Changes That Correlate With Altered Cognition.

Authors:  Hank P Jedema; Xiaowei Song; Howard J Aizenstein; Alexandra R Bonner; Elliot A Stein; Yihong Yang; Charles W Bradberry
Journal:  Biol Psychiatry       Date:  2020-08-18       Impact factor: 13.382

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.